Author:
Zhen Xuemei,Sun Xueshan,Dong Hengjin
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference48 articles.
1. Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region;Chen;Value Health,2008
2. Health technology assessment development in China;Chen;Int J Technol Assess Health Care,2009
3. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study;Zhang;BMJ Open,2014
4. Deloittee. The next phase: opportunities in China’s pharmaceuticals market. Available from: https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/ch_Studie_Pharmaceutical_China_05052014.pdf. [Accessed September 23, 2017].
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献